Heidelberg Pharma AG (ETR:HPHA)

Heidelberg Pharma AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is December - November.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 24, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020
Market Capitalization	130	112	129	266	177	162
Market Cap Growth	-13.03%	-13.03%	-51.73%	50.53%	9.59%	159.56%
Enterprise Value	101	75	84	272	164	153
Last Close Price	2.79	2.40	2.76	5.72	5.18	5.20
PS Ratio	18.98	16.33	13.05	14.39	87.04	18.64
PB Ratio	4.21	3.62	2.61	4.00	26.43	12.54
P/TBV Ratio	5.91	5.08	3.18	4.62	-	40.90
EV/Sales Ratio	14.71	11.02	8.49	14.68	80.41	17.60
Debt / Equity Ratio	0.01	0.01	0.12	0.24	1.59	0.02
Asset Turnover	0.11	0.11	0.12	0.30	0.10	0.41
Inventory Turnover	0.16	0.16	0.43	1.76	9.66	23.96
Quick Ratio	4.42	4.42	2.31	2.96	0.51	0.98
Current Ratio	5.95	5.95	2.86	3.15	0.60	1.14
Return on Equity (ROE)	-48.33%	-48.33%	-35.09%	-53.73%	-267.02%	-125.93%
Return on Assets (ROA)	-20.82%	-20.82%	-20.14%	-18.70%	-78.14%	-56.00%
Return on Capital (ROIC)	-31.65%	-31.65%	-24.99%	-22.88%	-106.22%	-81.22%
Earnings Yield	-14.91%	-17.33%	-15.82%	-7.39%	-14.77%	-11.37%
FCF Yield	-23.11%	-26.86%	-26.91%	-3.55%	-15.74%	-11.92%
Buyback Yield / Dilution	-0.02%	-0.02%	-25.14%	-14.56%	-8.72%	-5.98%

Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.